Ticagrelor monotherapy vs clopidogrel monotherapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention

被引：0
|
作者：
Feng, W. [1 ]
Chen, P. W. [2 ]
Ho, M. Y. [3 ]
Su, C. H. [4 ]
Huang, S. W. [4 ]
Cheng, C. W. [5 ]
Yeh, H., I [5 ]
Chen, C. P. [6 ]
Huang, W. C. [7 ]
Fang, C. C. [8 ]
Lin, H. W. [9 ]
Lin, S. H. [9 ]
Hsieh, I. C. [3 ]
Li, Y. H. [2 ]
机构：
[1] Kaohsiung Med Univ Hosp, Cardiol, Kaohsiung, Taiwan
[2] Natl Cheng Kung Univ Hosp, Cardiol, Tainan, Taiwan
[3] Linkou Chang Gung Mem Hosp, Cardiol, Taoyuan, Taiwan
[4] Chung Shan Med Univ Hosp, Cardiol, Taichung, Taiwan
[5] Mackay Mem Hosp, Cardiol, Taipei, Taiwan
[6] Changhua Christian Hosp, Cardiol, Changhua, Taiwan
[7] Kaohsiung Vet Gen Hosp, Cardiol, Kaohsiung, Taiwan
[8] Tainan Municipal Hosp, Cardiol, Tainan, Taiwan
[9] Natl Cheng Kung Univ, Tainan, Taiwan
来源：
EUROPEAN HEART JOURNAL | 2020年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1722 / 1722
页数：1
相关论文
共 50 条
  • [21] TicagRelor Or Clopidogrel in severe or terminal chronic kidney patients Undergoing PERcutaneous coronary intervention for acute coronary syndrome: The TROUPER trial
    Laine, Marc
    Lemesle, Gilles
    Burtey, Stephane
    Cayla, Guillaume
    Range, Gregoire
    Quaino, Gonzalo
    Canault, Matthias
    Pankert, Mathieu
    Paganelli, Franck
    Puymirat, Etienne
    Bonello, Laurent
    AMERICAN HEART JOURNAL, 2020, 225 : 19 - 26
  • [22] Prasugrel versus clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention
    Deepak L. Bhatt
    Current Atherosclerosis Reports, 2008, 10 (5) : 367 - 368
  • [23] A Comparative Study on Ticagrelor and Clopidogrel in Patients With Acute Coronary Syndrome Treated With Primary Percutaneous Coronary Intervention
    Wu, Hui
    Jia, Shaobin
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (07): : 776 - 783
  • [24] Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD
    Stefanini, Giulio G.
    Briguori, Carlo
    Cao, Davide
    Baber, Usman
    Sartori, Samantha
    Zhang, Zhongjie
    Dangas, George
    Angiolillo, Dominick J.
    Mehta, Shamir
    Cohen, David J.
    Collier, Timothy
    Dudek, Dariusz
    Escaned, Javier
    Gibson, C. Michael
    Gil, Robert
    Huber, Kurt
    Kaul, Upendra
    Kornowski, Ran
    Krucoff, Mitchell W.
    Kunadian, Vijay
    Moliterno, David J.
    Ohman, E. Magnus
    Oldroyd, Keith G.
    Sardella, Gennaro
    Sharma, Samin K.
    Shlofmitz, Richard
    Weisz, Giora
    Witzenbichler, Bernhard
    Pocock, Stuart
    Mehran, Roxana
    EUROPEAN HEART JOURNAL, 2021, 42 (45) : 4683 - 4693
  • [25] Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR
    Escaned, Javier
    Cao, Davide
    Baber, Usman
    Nicolas, Johny
    Sartori, Samantha
    Zhang, Zhongjie
    Dangas, George
    Angiolillo, Dominick J.
    Briguori, Carlo
    Cohen, David J.
    Collier, Timothy
    Dudek, Dariusz
    Gibson, Michael
    Gil, Robert
    Huber, Kurt
    Kaul, Upendra
    Kornowski, Ran
    Krucoff, Mitchell W.
    Kunadian, Vijay
    Mehta, Shamir
    Moliterno, David J.
    Ohman, E. Magnus
    Oldroyd, Keith G.
    Sardella, Gennaro
    Sharma, Samin K.
    Shlofmitz, Richard
    Weisz, Giora
    Witzenbichler, Bernhard
    Pocock, Stuart
    Mehran, Roxana
    EUROPEAN HEART JOURNAL, 2021, 42 (45) : 4624 - 4634
  • [26] Prasugrel or Ticagrelor for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Does it Matter?
    Giri, Jay
    Nathan, Ashwin
    JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (16) : 1587 - 1589
  • [27] Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary Intervention
    Watanabe, Hirotoshi
    Morimoto, Takeshi
    Natsuaki, Masahiro
    Yamamoto, Ko
    Obayashi, Yuki
    Nishikawa, Ryusuke
    Ando, Kenji
    Ono, Koh
    Kadota, Kazushige
    Suwa, Satoru
    Morishima, Itsuro
    Yoshida, Ruka
    Hata, Yoshiki
    Akao, Masaharu
    Yagi, Masahiro
    Suematsu, Nobuhiro
    Morino, Yoshihiro
    Yokomatsu, Takafumi
    Takamisawa, Itaru
    Noda, Toshiyuki
    Doi, Masayuki
    Okayama, Hideki
    Nakamura, Yuichi
    Hibi, Kiyoshi
    Sakamoto, Hiroki
    Noguchi, Teruo
    Kimura, Takeshi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (01) : 17 - 31
  • [28] Design and Rationale for comParison Between ticagreLor and clopidogrEl on mIcrocirculation in Patients with Acute cOronary Syndrome Undergoing Percutaneous Coronary Intervention (PLEIO) Trial
    Park, Kyungil
    Cho, Young-Rak
    Park, Jong-Sung
    Park, Tae-Ho
    Kim, Moo-Hyun
    Kim, Young-Dae
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2018, 11 (01) : 42 - 49
  • [29] Design and Rationale for comParison Between ticagreLor and clopidogrEl on mIcrocirculation in Patients with Acute cOronary Syndrome Undergoing Percutaneous Coronary Intervention (PLEIO) Trial
    Kyungil Park
    Young-Rak Cho
    Jong-Sung Park
    Tae-Ho Park
    Moo-Hyun Kim
    Young-Dae Kim
    Journal of Cardiovascular Translational Research, 2018, 11 : 42 - 49
  • [30] Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromes
    Koshy, Anoop N.
    Giustino, Gennaro
    Sartori, Samantha
    Hooda, Amit
    Feng, Yihan
    Snyder, Clayton
    Dasgupta, Shabitri
    Kumar, Kartik R.
    Krishnamoorthy-Melarcode, Parasuram
    Sweeny, Joseph
    Khera, Sahil
    Serrao, Gregory W.
    Sharma, Raman
    Dangas, George
    Kini, Annapoorna S.
    Mehran, Roxana
    Sharma, Samin K.
    EUROINTERVENTION, 2023, 18 (15) : 1244 - +
12345